Answers are grounded in this paper and cite their sources.
SLN mapping with ICG is feasible with a high detection rate and negative predictive value in low- and intermediate-risk endometrial cancers. Given the incidence of SLN metastases is approximately 10% in those patients, SLN mapping may lead to stage shifting with potential therapeutic consequences. Given the high negative predictive value with SLN mapping, routine lymphadenectomy should be omitted in low- and intermediate-risk endometrial cancer.
No takes yet. Share an insight, caveat, or question.
Burg et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: